Bicyclic amides

Details Bicyclic amides Bicyclic amides

2003-04-08

2010-02-23

Andres, Janet L. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07667053

ABSTRACT:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

REFERENCES:
patent: 4973587 (1990-11-01), Ward et al.
patent: 5013837 (1991-05-01), Ward et al.
patent: 5081122 (1992-01-01), Ward
patent: 5112820 (1992-05-01), Ward
patent: 5292734 (1994-03-01), Levin et al.
patent: 5420132 (1995-05-01), Guillaumet et al.
patent: 5439909 (1995-08-01), Guillaumet et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 6028084 (2000-02-01), Barth et al.
patent: 6344474 (2002-02-01), Maruani et al.
patent: 2004/0058820 (2004-03-01), Hagmann et al.
patent: 0072286 (1983-02-01), None
patent: 0401676 (1990-12-01), None
patent: 0 656 354 (1995-06-01), None
patent: 596326 (1995-08-01), None
patent: 0 736 529 (1996-10-01), None
patent: 658546 (2001-05-01), None
patent: 1 328 269 (2004-05-01), None
patent: 11080124 (1999-03-01), None
patent: 2000-506138 (2000-05-01), None
patent: WO 96/25426 (1996-08-01), None
patent: WO 96/33159 (1996-10-01), None
patent: WO 97/29079 (1997-08-01), None
patent: WO 97/31940 (1997-09-01), None
patent: WO 98/31227 (1998-07-01), None
patent: WO 98/36749 (1998-08-01), None
patent: WO 98/37061 (1998-08-01), None
patent: WO 98/41519 (1998-09-01), None
patent: WO 98/56754 (1998-12-01), None
patent: WO 99/02499 (1999-01-01), None
patent: WO 99/42086 (1999-08-01), None
patent: WO 00/10967 (2000-03-01), None
patent: WO 00/10968 (2000-03-01), None
patent: WO 00/61608 (2000-10-01), None
patent: WO 01/09120 (2001-02-01), None
patent: WO 01/58450 (2001-08-01), None
patent: WO 01/85092 (2001-11-01), None
patent: WO 02/076945 (2002-10-01), None
patent: WO 03/077847 (2003-09-01), None
patent: WO 03/082190 (2003-10-01), None
patent: WO 03/082256 (2003-10-01), None
patent: WO 03/087037 (2003-10-01), None
patent: WO 2004/040040 (2004-05-01), None
U.S. Appl. No. 60/504,377, Armstrong et al.
U.S. Appl. No. 10/507,864, Hagmann et al.
U.S. Appl. No. 60/515,705, Shah et al.
U.S. Appl. No. 60/483,679, Burns et al.
Barth, Exp. Opin. Ther. Patents, vol. 8 (1998), pp. 301-313, “Cannabinoid receptor agonists and antagonists”.
Xiang et al., Ann. Rep. Med. Chem., A. Doherty, ed., Academic Press, NY (1999), vol. 34, pp. 199-208, “Chap. 20. Pharmacology of cannabinoid receptor agonists and antagonists”.
Goya et al., Exp. Opin. Ther. Patents, vol. 10 (2000), pp. 1529-1538, “Recent advances in cannabinoid receptor agonists and antagonists”.
Piomelli et al., Trends in Pharm. Sci., vol. 21 (2000), pp. 218-224, “The endocannabinoid system as a target for therapeutic drugs”.
Lack et al., J. Pharmacol. & Exper. Thera., Am. Soc. for Pharmacol. & Exper. Therapeutic, US, vol. 139 (1963), pp. 248-258, “The intestinal action of benzmalecene: The relationship of its hypocholesterolemic effect . . . ”.

Affiliated with

Also associated with

Rating

Bicyclic amides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic amides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4169742